BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20236105)

  • 1. Association study of four key folliculogenesis genes in polycystic ovary syndrome.
    Sproul K; Jones MR; Mathur R; Azziz R; Goodarzi MO
    BJOG; 2010 May; 117(6):756-60. PubMed ID: 20236105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of AMH and its receptor SNP in the pathogenesis of PCOS.
    Wang F; Niu WB; Kong HJ; Guo YH; Sun YP
    Mol Cell Endocrinol; 2017 Jan; 439():363-368. PubMed ID: 27664518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
    J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes involved in initial follicle recruitment may be associated with age at menopause.
    Voorhuis M; Broekmans FJ; Fauser BC; Onland-Moret NC; van der Schouw YT
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E473-9. PubMed ID: 21193543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients.
    Kevenaar ME; Laven JS; Fong SL; Uitterlinden AG; de Jong FH; Themmen AP; Visser JA
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1310-6. PubMed ID: 18230658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.
    Georgopoulos NA; Karagiannidou E; Koika V; Roupas ND; Armeni A; Marioli D; Papadakis E; Welt CK; Panidis D
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1866-70. PubMed ID: 23969185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Polymorphisms in Anti-Müllerian Hormone (AMH Ile49Ser) and its Type II Receptor (AMHRII -482 A>G) on Reproductive Outcomes and Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis.
    Pabalan N; Montagna E; Singian E; Tabangay L; Jarjanazi H; Barbosa CP; Bianco B
    Cell Physiol Biochem; 2016; 39(6):2249-2261. PubMed ID: 27832628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome.
    Szafarowska M; Dziech E; Kaleta B; Kniotek M; Rogowski A; Segiet-Święcicka A; Jerzak M
    J Assist Reprod Genet; 2019 Jun; 36(6):1281-1289. PubMed ID: 31089932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Genetic Variation in the Anti-Müllerian Hormone Pathway in Women With Polycystic Ovary Syndrome.
    Gorsic LK; Dapas M; Legro RS; Hayes MG; Urbanek M
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2855-2874. PubMed ID: 30786001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome.
    Pierre A; Taieb J; Giton F; Grynberg M; Touleimat S; El Hachem H; Fanchin R; Monniaux D; Cohen-Tannoudji J; di Clemente N; Racine C
    J Clin Endocrinol Metab; 2017 Nov; 102(11):3970-3978. PubMed ID: 28938480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome.
    Czeczuga-Semeniuk E; Jarząbek K; Galar M; Kozłowski P; Sarosiek NA; Zapolska G; Wołczyński S
    Endocrine; 2015 Apr; 48(3):1001-4. PubMed ID: 25012254
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal expression of growth differentiation factor 9 and bone morphogenetic protein 15 in stimulated oocytes during maturation from women with polycystic ovary syndrome.
    Wei LN; Liang XY; Fang C; Zhang MF
    Fertil Steril; 2011 Aug; 96(2):464-8. PubMed ID: 21669410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.
    Kevenaar ME; Themmen AP; van Kerkwijk AJ; Valkenburg O; Uitterlinden AG; de Jong FH; Laven JS; Visser JA
    Hum Reprod; 2009 Jan; 24(1):241-9. PubMed ID: 18854405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone (AMH), inhibin-α, growth differentiation factor 9 (GDF9), and bone morphogenic protein-15 (BMP15) mRNA and protein are influenced by photoperiod-induced ovarian regression and recrudescence in Siberian hamster ovaries.
    Shahed A; Young KA
    Mol Reprod Dev; 2013 Nov; 80(11):895-907. PubMed ID: 23877969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 During IVF and in Women With Reproductive Pathologies.
    Riepsamen AH; Chan K; Lien S; Sweeten P; Donoghoe MW; Walker G; Fraison EHJ; Stocker WA; Walton KL; Harrison CA; Ledger WL; Robertson DM; Gilchrist RB
    Endocrinology; 2019 Oct; 160(10):2298-2313. PubMed ID: 31211369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change and significance of growth differentiation factor 9 and bone morphogenetic protein expression during oocyte maturation in polycystic ovary syndrome patients with ovarian stimulation].
    Wei LN; Fang C; Huang R; Li LL; Zhang MF; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):818-22. PubMed ID: 23302121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bone Morphogenetic Protein 15 Up-Regulates the Anti-Müllerian Hormone Receptor Expression in Granulosa Cells.
    Pierre A; Estienne A; Racine C; Picard JY; Fanchin R; Lahoz B; Alabart JL; Folch J; Jarrier P; Fabre S; Monniaux D; di Clemente N
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2602-11. PubMed ID: 27070094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome.
    Riepsamen AH; Donoghoe MW; Indran IR; Hechtman L; Robertson DM; Gilchrist RB; Ledger WL; Yong EL
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):567-577. PubMed ID: 36372988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDF9 and BMP15 Expressions and Fine Structure Changes During Folliculogenesis in Polycystic Ovary Syndrome.
    Karagül Mİ; Aktaş S; Coşkun Yılmaz B; Yılmaz M; Orekici Temel G
    Balkan Med J; 2018 Jan; 35(1):43-54. PubMed ID: 28903889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced and delayed expression of GDF9 and BMP15 in ovarian tissues from women with polycystic ovary syndrome.
    Wei LN; Huang R; Li LL; Fang C; Li Y; Liang XY
    J Assist Reprod Genet; 2014 Nov; 31(11):1483-90. PubMed ID: 25172094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.